ULBI - Ultralife Corporation

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate0.020.110.230.61
Low estimate0.020.110.230.61
High estimate0.020.110.230.61
Year ago EPS-0.010.03N/A0.23
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate33M36M134M149M
Low estimate33M36M134M149M
High estimate33M36M134M149M
Year ago sales32.13M33.23M131.84M134M
Sales growth (year/est)2.70%8.30%1.60%11.20%
Earnings history30/03/202229/06/202229/09/202230/03/2023
Est. EPS-0.050.010.04-0.1
Actual EPS-0.010.03-0.01-0.01
Difference0.040.02-0.050.09
Surprise %80.00%200.00%-125.00%90.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate0.020.110.230.61
7 days ago0.020.110.230.61
30 days ago0.020.110.230.61
60 days ago0.150.170.550
90 days ago0.150.170.550
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesULBIIndustrySector(s)S&P 500
Current qtr.300.00%N/AN/AN/A
Next qtr.266.70%N/AN/AN/A
Current yearN/AN/AN/AN/A
Next year165.20%N/AN/AN/A
Next 5 years (per annum)17.50%N/AN/AN/A
Past 5 years (per annum)-4.87%N/AN/AN/A